Industry association · Belgium · EU Transparency Register 06818218065-85
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Among the 1205 trade and business associations on this site, they rank #245 by legislative files engaged — a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track IBMA in PolicySpeak: request access →
Work at IBMA - International Biocontrol Manufacturers Association? so we know who speaks for it.
IBMA - International Biocontrol Manufacturers Association filed 7 positions between 12 Apr 2022 and 14 Jul 2026, across 6 of the 326 legislative files tracked here, attaching a full position paper 5 times.
14 July 2026 Biotech Act I IBMA, the International Biocontrol Manufacturers Association Feedback IBMA, the association representing biological control manufacturers in Europe and globally since 1995, with over 200 members, welcomes the European Commission's initiative to develop a European Biotech Act I.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
11 June 2025 The EU Biotech Act – an opportunity to drive the uptake of biocontrol IBMA, the association representing biological control manufacturers in Europe and globally, welcomes the European Commission’s plans for a European Biotech Act.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
IBMA, the association representing biological control manufacturers in Europe and globally since 1995, with over 200 members, welcomes the European Commission's initiative to develop a Biotech Act II and its ambition to establish an enabling regulatory framework for industrial biotechnology and biomanufacturing in Europe. Please read our answer here attached.
IBMA, the International Biocontrol Manufacturers Association with its over 230 members of which 85% SMEs, welcomes this public consultation. It regards a crucial matter for the future, in particular when it comes to PPPs such as biocontrol solutions, and therefore for the transition to a future more sustainable agriculture using agroecological farming practices, as per the EU Green Deal and Strategies objectives.
IBMA has shared the survey with its members, who will provide the requested information (deadline set by ENV: 28 February). Regarding the general Call for Evidence, IBMA understands that the implementation of the Nagoya Protocol and the respective EU legislation is primarily targeted at Member States.
IBMA International Biocontrol Manufacturers Association welcomes the EU Commission's initiative in launching a "Call for Evidence" allowing stakeholders to provide feedback for the evaluation of EFSA's performance from 2017 to 2024. IBMA has observed a noticeable increase in EFSA's willingness to engage with stakeholders, and we appreciate the significant steps made towards greater openness and transparency.
IBMA would like to thank the European Commission for the opportunity to provide comments on the new Draft Data Requirements for applications to approve active substances. Please find attached our general feedback together with the detailed commenting tables.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 107.
Everything on this page comes from IBMA - International Biocontrol Manufacturers Association’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.